The path to improved safety of gene-based products
Drug Discovery World
MAY 11, 2023
First, products containing undesired proteases can impair drug stability, either by degrading the drug itself or by degrading stabilising excipients of the drug formulation, which ultimately diminishes the drug’s durability. In the case of therapeutics, the aim is usually to avoid patients’ immune responses.
Let's personalize your content